Vioxx/Celebrex/Bextra Recall News Center

A totally independent source of information from MYNIPPON
-

Note to visitors

  1. If you want the latest news, proceed directly to the news center of Vioxx/Celebrex/Bextra recall.  

  2. If you want to read a specific article, the list of articles published is below arranged chronologically with latest articles on top.  

  3. Or simply do a keyword search.

Merck held responsible for the death of Leonel Garza
Merck loses Vioxx case of John McDarby
Date set for first Celebrex trial
New England Journal of Medicine reaffirms that Merck lied about Vioxx safety
Merck wins in the retrial of the federal Vioxx case
Merck in trouble in ongoing trials
Leonel Garza trial in progress
Garza Vioxx trial preparations underway
Federal Vioxx lawsuits may be tried in state courts
Health Canada permanently bans Bextra
Can Cleveland Clinic do the Celebrex PRECISION study fairly?
Number of Vioxx lawsuits reach a record 9,200
Pfizer to fund research to assess safety of Celebrex in PRECISION trial
First federal Vioxx trial ends in a mistrial
Merck fudged VIGOR data to make Vioxx look safer than it actually was
Merck's defense attacked by Dr. Eric Topol
Vioxx, Celebrex, Bextra, and Cox-2 drugs have no benefits
Merck lays off thousands of employees as federal Vioxx trial begins in Houston
Federal Vioxx trial preparations completed
Major setback for Merck from Judge Carol Higbee
Challenges ahead for Merck in federal Vioxx trial
No relief for Merck from Vioxx lawsuits
Merck overwhelmed by Vioxx lawsuits
Merck had total disregard for scientific approach in Vioxx safety studies
Merck likely to lose second Vioxx trial in Atlantic City
Merck has a weak position in its defense in the Humeston case
Merck will find it difficult to defend itself
Merck did not make Vioxx death data public
Merck knew about deaths of Vioxx patients but chose to ignore them
Richard Kronmal, statistics expert, charges Merck with deliberately ignoring safety issues
Vioxx victims in Puerto Rico file lawsuit against Merck
Dynastat (parecoxib) not approved by FDA
Merck's central argument about safety of Vioxx blasted by Lucchesi
Merck suffers several setbacks during first week of Humeston case
New Jersey Vioxx lawsuit trial commences
Profiles of Chris Seeger and Frederick "Mike" Humeston
Merck in total chaos due to Vioxx litigation
Merck faces a war hero in second Vioxx trial
Merck also expected to lose Vioxx class action lawsuit in New Jersey
Legal experts await the New Jersey trial in the lawsuit by Mike Humeston
Merck agrees to settle some cases out of court
Merck internal documents help Vioxx victims
Merck continues to attack Vioxx plaintiffs
Merck likely to settle Vioxx cases out of court
More trouble ahead for Merck after loss in Texas
Vioxx victim received $250 million in damages
Merck loses Texas case
Merck expected to lose Texas Vioxx lawsuit
Merck and Texas AG spar over Vioxx lawsuit
Federal Vioxx trial to start in November
Merck appears to be in trouble in ongoing Vioxx trial in Texas
Carol Ernst feels sense of guilt for Robert's death
Merck admits to aggressive marketing of Vioxx
Merck receives major setbacks in Vioxx trial
Vioxx plaintiff receives help from coroner
Damaging testimony presented in Vioxx trial
How many deaths from Vioxx?
Vioxx killed Robert Ernst, cardiologist says
Merck's financial problems worsen with Vioxx lawsuits
Merck lied to doctors about risks of Vioxx
Merck accused of using animal data to justify Vioxx safety
More risks of Vioxx and other Cox-2 drugs found
Documents to show that Merck hid Vioxx risks deliberately
Trial in the case of Carol Ernst begins
Canada may resume sales of Vioxx
Vioxx trial in Texas to go ahead
Merck seeks delay in Carol Ernst trial
Oregon Vioxx victims may be able to sue Merck
Texas AG sues Merck in Vioxx recall case
Merck wants an image makeover after Vioxx fiasco
Vioxx trial moves ahead in Houston
Bextra ban reconfirmed in Europe
Merck knew of Vioxx risks despite its denials so far
Vioxx trial delay sought by conservative group
Merck intimidated Vioxx critics prior to recall
Arcoxia (etoricoxib) approval delayed by the FDA
Heart attack risks of Diclofenac and ibuprofen may force a recall of these drugs
Nexium combination with painkiller is an alternative to arthritis patients
Oregon Vioxx victims unable to sue Merck
Recall of Vioxx and Bextra leaves prescription drug advertising unchanged
Risks of NSAIDs
Bextra and Celebrex maker Pfizer again in trouble over Viagra
Risks of all Cox-2 inhibitor drugs
Vioxx recall lawsuits to exceed 100,000
Aleve is an option after Vioxx and Bextra recall
Pfizer continues to defend Bextra and calls it safe
Canadian panel to review Cox-2 drugs
Bextra recall seems to help Celebrex sales
More studies prior to Vioxx recall were needed
Bextra recall to be reversed, Pfizer says
New Zealand acts on Vioxx, Celebrex, and Bextra
Merck sold Vioxx ruthlessly prior to recall
Merck CEO fired over Vioxx recall controversy
Vioxx recall lawsuits likely to be delayed
FDA incapable of ensuring drug safety in America
Merck hid Vioxx risks prior to recall
Vioxx lawsuits against Merck to go to trial
Bextra class action lawsuits being filed
Frequently asked questions about Vioxx, Celebrex, and Bextra Vioxx, Celebrex, Bextra blog help and FAQ Advertising opportunity on Vioxx, Celebrex, Bextra news center
Contact us About us Advertising information Privacy policy Search eCreativa network
iProceed eBusiness blog Find/Live/Enjoy Love Consultant blog Blog posts Lindisima
Latinas LuvCube blog Social Security privatization Vioxx/Celebrex/
Bextra recall		 Archives Management Consultant
e-books Pierre Coda Social Security privatization list of articles Vioxx, Celebrex, Bextra Lifestyle news MYNIPPON fitness center

Copyright.  All rights reserved.